Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03020030
Title Treatment of Newly Diagnosed Acute Lymphoblastic Leukemia in Children and Adolescents
Recruitment Recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors Dana-Farber Cancer Institute
Indications

acute lymphoblastic leukemia

Therapies

Nelarabine

Dexrazoxane

Asparaginase

Vincristine Sulfate

Cyclophosphamide

Cytarabine

Mercaptopurine

Pegaspargase

Methotrexate

Etoposide

Doxorubicin

Dexamethasone

Prednisone

Dasatinib

Leucovorin

Age Groups: child | adult
Covered Countries USA | CAN


No variant requirements are available.